01/ 2025 In this Perspective piece you can find more information on A-STAR and the baseline characteristics of the cohort.
Read the paper: New publication: The UK-Irish Atopic eczema Systemic TherApy Register (A*STAR): baseline characteristics of the cohort
01/ 2025 A big milestone has been hit recently by the Norwich and Norfolk team who recruited the 1000th patient onto ASTAR! Big thank you to all the people involved into the study across the 50 sites in the UK!
07/2024 A prospective observational cohort study comparing the treatment effectiveness and safety of ciclosporin, dupilumab and methotrexate in adult and paediatric patients with atopic dermatitis: results from the UK-Irish A-STAR register
Read paper: Comparative Effectiveness of Ciclosporin, Dupilumab, and Methotrexate in Atopic Dermatitis
03/2023 Comparison of real-world treatment outcomes of systemic immunomodulating therapy in atopic dermatitis patients with dark and light skin types
Read paper: Real-World Treatment Outcomes by Skin Type
01/2023 Comparison of real-world treatment outcomes of systemic immunomodulating therapy in atopic dermatitis patients with dark and light skin types
Read paper: Comparison of real-world treatment outcomes of systemic immunomodulating therapy in atopic dermatitis patients with dark and light skin types
12/2022 Read our last newsletter of 2022 for updates and news
Download newsletter: A-STAR Newsletter Dec 2022
25/11/2022 A thank you to all involved and information about our expansion
Download newsletter: A-STAR Newsletter Nov 2022
25/11/2022 We have now recruited our 400th participant into the register. Thank you and well done to all of our A-STAR team members for passing this milestone!
05/10/2018 Guy’s and St Thomas’ paediatric department has enrolled the first patient in A-STAR.
28/09/2018 Guy’s and St Thomas’ NHS Foundation Trust is now open to recruitment to participants of all ages.
26/07/2018 The Wales Research Ethics Committee 1 agreed to give favourable ethical opinion to A*STAR on 26/07/2018
13/07/2017 Dr Carsten Flohr has been awarded a BSF grant for the study: ‘The UK-Irish Atopic Eczema Systemic Therapy Cohort’. More information is available in the BAD Newsletter, Autumn 2017, Volume 20 Number 3, p12-13,
